📰 Libra Wealth News
Page 6 - Libra Wealth News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Libra Wealth. Real-time updates on events, politics, business and more.
April 4, 2023
Hoxton Planning & Management LLC bought a new stake in shares of AbbVie Inc. (NYSE:ABBV – Get Rating) in the fourth quarter, Holdings Channel reports. The firm bought 1,408 shares of the company’s stock, valued at approximately $228,000. Other hedge funds and other institutional investors also recently bought and sold shares of the company. GYL […]
April 4, 2023
Grimes & Company Inc. boosted its holdings in AbbVie Inc. (NYSE:ABBV – Get Rating) by 3.5% during the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The fund owned 91,384 shares of the company’s stock after acquiring an additional 3,096 shares during the period. AbbVie accounts […]
April 3, 2023
Koshinski Asset Management Inc. grew its stake in AbbVie Inc. (NYSE:ABBV – Get Rating) by 0.7% during the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 46,111 shares of the company’s stock after acquiring an additional 339 shares during the period. AbbVie accounts […]
April 3, 2023
Kooman & Associates bought a new position in shares of AbbVie Inc. (NYSE:ABBV – Get Rating) in the fourth quarter, Holdings Channel.com reports. The fund bought 3,521 shares of the company’s stock, valued at approximately $569,000. AbbVie makes up approximately 0.6% of Kooman & Associates’ investment portfolio, making the stock its 21st biggest holding. A […]
April 2, 2023
Phillips Financial Management LLC grew its stake in shares of AbbVie Inc. (NYSE:ABBV – Get Rating) by 7.5% during the 4th quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The institutional investor owned 2,597 shares of the company’s stock after acquiring an additional 181 shares during the […]
April 1, 2023
Community Bank of Raymore boosted its position in shares of AbbVie Inc. (NYSE:ABBV – Get Rating) by 189.8% during the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The fund owned 14,013 shares of the company’s stock after purchasing an additional 9,178 shares during the period. AbbVie comprises […]
March 31, 2023
Strategic Advisors LLC trimmed its stake in AbbVie Inc. (NYSE:ABBV – Get Rating) by 3.8% in the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 76,663 shares of the company’s stock after selling 3,042 shares during the period. AbbVie comprises 2.8% of […]
March 31, 2023
Should You Buy or Sell AbbVie Stock? Get The Latest ABBV Stock Forecast, Price Target, Dividend Info, Headlines, Short Interest at MarketBeat.
March 29, 2023
Keudell Morrison Wealth Management decreased its holdings in shares of AbbVie Inc. (NYSE:ABBV – Get Rating) by 1.4% during the 4th quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 26,257 shares of the company’s stock after selling 385 shares during the period. […]
March 28, 2023
Sterling Investment Counsel LLC lifted its holdings in AbbVie Inc. (NYSE:ABBV – Get Rating) by 3.9% during the fourth quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The fund owned 2,756 shares of the company’s stock after buying an additional 103 shares during the period. Sterling […]